Guardant Health Inc (GH)
18.88
+0.30
(+1.61%)
USD |
NASDAQ |
May 03, 16:00
18.90
+0.02
(+0.13%)
After-Hours: 20:00
Guardant Health Enterprise Value: 2.273B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 2.273B |
May 02, 2024 | 2.236B |
May 01, 2024 | 2.197B |
April 30, 2024 | 2.165B |
April 29, 2024 | 2.188B |
April 26, 2024 | 2.086B |
April 25, 2024 | 2.063B |
April 24, 2024 | 2.177B |
April 23, 2024 | 2.085B |
April 22, 2024 | 2.115B |
April 19, 2024 | 1.930B |
April 18, 2024 | 2.003B |
April 17, 2024 | 1.969B |
April 16, 2024 | 1.941B |
April 15, 2024 | 2.051B |
April 12, 2024 | 2.194B |
April 11, 2024 | 2.245B |
April 10, 2024 | 2.297B |
April 09, 2024 | 2.308B |
April 08, 2024 | 2.242B |
April 05, 2024 | 2.117B |
April 04, 2024 | 2.180B |
April 03, 2024 | 2.369B |
April 02, 2024 | 2.502B |
April 01, 2024 | 2.436B |
Date | Value |
---|---|
March 28, 2024 | 2.482B |
March 27, 2024 | 2.157B |
March 26, 2024 | 2.124B |
March 25, 2024 | 2.056B |
March 22, 2024 | 2.071B |
March 21, 2024 | 2.109B |
March 20, 2024 | 2.154B |
March 19, 2024 | 2.155B |
March 18, 2024 | 2.095B |
March 15, 2024 | 2.131B |
March 14, 2024 | 2.207B |
March 13, 2024 | 2.284B |
March 12, 2024 | 2.240B |
March 11, 2024 | 2.283B |
March 08, 2024 | 2.373B |
March 07, 2024 | 2.389B |
March 06, 2024 | 2.218B |
March 05, 2024 | 2.256B |
March 04, 2024 | 2.274B |
March 01, 2024 | 2.280B |
February 29, 2024 | 2.284B |
February 28, 2024 | 2.251B |
February 27, 2024 | 2.348B |
February 26, 2024 | 2.423B |
February 23, 2024 | 2.335B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.930B
Minimum
Apr 19 2024
17.02B
Maximum
Feb 12 2021
6.975B
Average
6.585B
Median
Dec 03 2019
Enterprise Value Benchmarks
Exact Sciences Corp | 12.85B |
Illumina Inc | 19.17B |
Delcath Systems Inc | 119.14M |
CytoSorbents Corp | 38.69M |
Progyny Inc | 2.690B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -187.04M |
Revenue (Quarterly) | 155.05M |
Total Expenses (Quarterly) | 352.56M |
EPS Diluted (Quarterly) | -1.58 |
Gross Profit Margin (Quarterly) | 59.68% |
Profit Margin (Quarterly) | -120.6% |
Earnings Yield | -22.67% |
Normalized Earnings Yield | -22.67 |